Shopping Cart
- Remove All
Your shopping cart is currently empty
CCT020312 (0-9 µM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB signaling with linear response values between 1.8 and 6.1 µM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $56 | In Stock | |
| 5 mg | $143 | In Stock | |
| 10 mg | $253 | In Stock | |
| 25 mg | $429 | In Stock | |
| 50 mg | $635 | In Stock | |
| 100 mg | $883 | In Stock | |
| 500 mg | $1,830 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $198 | In Stock |
| Description | CCT020312 (0-9 µM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB signaling with linear response values between 1.8 and 6.1 µM. |
| In vitro | METHODS: CCT020312 (0-9 µM, 24 h) treated medium HT29 cells for 24 h. Ser608 pRB phosphorylation was quantified using a cell-based immunoassay. RESULTS Concentration-dependent loss of P-S608-pRB signaling was observed with linear response values between 1.8 and 6.1 µM. [1] |
| In vivo | METHODS: CCT020312 (2 mg/kg, intraperitoneal injection, starting at 17 weeks for 6 weeks) was used to treat P301S tau transgenic mice to test for mouse-specific visuospatial memory deficits. RESULTS P301S tau transgenic mice performed significantly better in the Morris water maze. [2] |
| Molecular Weight | 650.4 |
| Formula | C31H30Br2N4O2 |
| Cas No. | 324759-76-4 |
| Smiles | CCN(CC)CCC(=O)N1N=C(CC1c1ccc(Br)cc1)c1c(-c2ccccc2)c2cc(Br)ccc2[nH]c1=O |
| Relative Density. | 1.48 g/cm3 (Predicted) |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 145 mg/mL (222.94 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (6.15 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.